Zevra Therapeutics, Inc. (ZVRA) Free cash flow 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.4MFY2025 · since FY2016: -$30.4M → -$2.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.4M | +96.5% |
| FY2024 | -$69.7M | -105.9% |
| FY2023 | -$33.8M | -79.9% |
| FY2022 | -$18.8M | -282.0% |
| FY2021 | $10.3M | +624.2% |
| FY2020 | -$2.0M | +91.7% |
| FY2019 | -$23.8M | +56.2% |
| FY2018 | -$54.2M | -62.9% |
| FY2017 | -$33.3M | -9.4% |
| FY2016 | -$30.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice